Huperzine A is a chemical compound that can be isolated from the plant Huperzia serrata (Chinese membership moss), a conventional Chinese remedy used for contusions, strains, swelling, and schizophrenia. It can be made in a laboratory. Huperzine A is often listed as "Huperzia serrata extract," "HupA," or "Chinese membership moss" on dietary supplement product labels. It is usually marketed for brain booster supplement well being and cognitive performance, with claims of enhanced Mind Guard brain health energy, memory, alertness, consideration, focus, and focus. No dependable scientific proof helps using huperzine A to enhance cognitive efficiency. Multi-ingredient merchandise containing huperzine A may very well be unsafe. Is it an accredited dietary supplement ingredient? Although it's marketed within the U.S. A is an permitted drug in some other nations. For instance, huperzine A is obtainable in most hospitals in China and is used to "treat" Alzheimer’s illness. Within the U.S., nevertheless, it is unclear whether huperzine A could be legally marketed as a dietary complement. Is huperzine A efficient as a dietary complement?

To this point, no studies have proven huperzine A to enhance cognitive efficiency in otherwise wholesome individuals. Preliminary proof suggests huperzine may need helpful results on cognitive function amongst Alzheimer’s illness patients, but more research is required to ascertain this conclusively. Some companies have been advertising and marketing "supplements" containing huperzine A with unlawful claims that their products can "treat" Alzheimer’s. Is huperzine A secure as a dietary complement? Currently, the Alzheimer’s Association recommends not taking huperzine A, particularly with prescription medication, as a result of the mix could improve the danger of serious unwanted effects. Taking huperzine A in combination with other dietary brain clarity supplement ingredients (especially ones marketed as nootropics) would possibly pose extra mind guard brain health supplement dangers. Overall, safety data is lacking and lengthy-term use shouldn't be properly understood. As well as, multi-ingredient merchandise containing huperzine A have been proven to contain varying quantities of huperzine A inconsistent with the Supplement Facts label, in addition to ingredients not allowed in dietary supplements.

Can Military Service Members use huperzine A? Huperzine A is just not prohibited to be used by DoD members, and it won't trigger a positive consequence on a routine military drug test. However, given the restricted proof of its safety, we advise caution with merchandise that comprise this ingredient. As well as, some dietary supplement products containing huperzine A embrace substances prohibited to be used. Consuming such elements could put your well being, career, or both in danger. In some cases, these substances might not be listed on a product’s label, so you possibly can devour prohibited elements unknowingly. Using products that have been third-occasion certified can enable you to keep away from this possibility. Bridwell, R. E., Yoo, M. J., Grove, Mind Guard brain health J. J., & Ng, P. C. (2020). Chest ache from nootropic brain supplement use in an lively responsibility soldier: A case report. Military Medicine, 185(9-10), e1857-e1859. Hao, Z., Liu, M., Liu, Z., & Lu, D. (2009). Huperzine A for vascular dementia.

Cochrane Database of Systematic Reviews, 2009(2), Article CD007365. Huang, P., Li, B., Guo, Y.-H., Feng, S., Hu, J., & Liu, Q.-Q. 2019). Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: A systematic overview and meta-evaluation (in Chinese). Jędrejko, K., Catlin, O., Stewart, T., Anderson, A., Muszyńska, B., & Catlin, D. H. (2023). Unauthorized components in "nootropic brain supplement" dietary supplements: A review of the history, pharmacology, Mind Guard brain health prevalence, worldwide rules, and potential as doping agents. Li, J., Wu, H. M., Zhou, R. L., Liu, G. J., Dong, B. R., & Wu, H. M. (2008). Huperzine A for Alzheimer's disease. Cochrane Database of Systematic Reviews, 2008(2), Article CD005592. Morasch, K. C., Aaron, C. L., Moon, J. E., & Gordon, R. K. (2015). Physiological and neurobehavioral results of cholinesterase inhibition in wholesome adults. Rafii, M. S., Walsh, S., Little, J. T., Behan, K., Reynolds, B., Ward, C., . Aisen, P. S. (2011). A part II trial of huperzine A in mild to moderate Alzheimer disease.

Tucker, J., Fischer, T., Upjohn, L., Mazzera, D., & Kumar, M. (2018). Unapproved pharmaceutical elements included in dietary supplements related to U.S. Food and Drug Administration warnings. JAMA Network Open, 1(6), Article e183337. U. S. Food & Drug Administration. 2019). FDA takes motion against 17 firms for illegally promoting merchandise claiming to treat Alzheimer’s disease. U.S. Food & Drug Administration. 2023). CFSAN antagonistic event reporting system (CAERS). Wessinger, C. M., Inman, C. L., Weinstock, J., & Weiss, E. P. (2021). Effect of huperzine A on cognitive function and perception of effort during exercise: A randomized double-blind crossover trial. Yang, G., Wang, Y., Tian, J., & Liu, J.-P. 2013). Huperzine A for Alzheimer’s disease: A systematic review and meta-evaluation of randomized clinical trials. PLoS ONE, 8(9), Article e74916. Yue, J., Dong, B. R., Lin, X., Yang, M., Wu, H. M., & Wu, T. (2012). Huperzine A for mild cognitive impairment. Cochrane Database of Systematic Reviews, 2012(12), Article CD008827.